Cancer BiologybioRxivPreprint
EML4-ALK V3 drives cell migration through NEK9 and NEK7 kinases in non-small-cell lung cancer
Laura O’Regan, Giancarlo Barone, Rozita Adib…·Andrew M. Fry
The paper shows EML4-ALK V3 promotes cell migration via NEK9 and NEK7 kinases, leading to worse outcomes in lung cancer.
DOI 10.1101/567305